Cited by 246Cannabis and Cannabinoid ResearchStress Responses and CortisolTreatment of Major Depression

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment

Open access

Hill, Matthew N., Carrier, Erica J., McLaughlin, Ryan J., Morrish, Anna C., Meier, Sarah E., Hillard, Cecilia J., Gorzalka, Boris B.·2008·Journal of Neurochemistry

DOI 10.1111/j.1471-4159.2008.05567.xPMC PMC2606621

Open this paper in CoChat — free account

Abstract

It has been suggested that disturbances in endocannabinoid signaling contribute to the development of depressive illness; however, at present there is insufficient evidence to allow for a full understanding of this role. To further this understanding, we performed an analysis of the endocannabinoid system in an animal model of depression. Male rats exposed to chronic, unpredictable stress (CUS) for 21 days exhibited a reduction in sexual motivation, consistent with the hypothesis that CUS in rats induces depression‐like symptoms. We determined the effects of CUS, with or without concurrent treatment with the antidepressant imipramine (10 mg/kg), on CP55940 binding to the cannabinoid CB 1 receptor; whole tissue endocannabinoid content; and fatty acid amide hydrolase (FAAH) activity in the prefrontal cortex, hippocampus, hypothalamus, amygdala, midbrain and ventral striatum. Exposure to CUS resulted in a significant increase in CB 1 receptor binding site density in the prefrontal cortex and a decrease in CB 1 receptor binding site density in the hippocampus, hypothalamus and ventral striatum. Except in the hippocampus, these CUS‐induced alterations in CB 1 receptor binding site density were attenuated by concurrent antidepressant treatment. CUS alone produced a significant reduction in N‐arachidonylethanolamine (anandamide) content in every brain region examined, which was not reversed by antidepressant treatment. These data suggest that the endocannabinoid system in cortical and subcortical structures is differentially altered in an animal model of depression and that the effects of CUS on CB 1 receptor binding site density are attenuated by antidepressant treatment while those on endocannabinoid content are not.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2008.05567.x

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605
Limbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
Cota, D., Marsicano, G., Tschöp, M. H., Grübler, Y., Flachskamm, C., Schubert, M. I., Auer, D. P., Yassouridis, A., Thöne‐Reineke, C., Ortmann, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17725 · Cited by 1,168
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · cited 4×
“Anhedonia is a core symptom of major depression, and a behavioral phenomenon typically seen in rodents following CUS/CMS (Willner et al. 1992; Willner 2005).”
BackgroundInfluential
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 829
Depression as a risk factor for cardiac mortality and morbidity
Carney, R. M., Freedland, K. E., Miller, G. E., & Jaffe, A. S. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00311-2 · Cited by 746
Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression
López, J. F., Chalmers, D. T., Little, K. Y., & Watson, S. J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00484-8 · Cited by 700
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
Gobbi, G., Bambico, F. R., Mangieri, R. A., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509591102 · Cited by 692
Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain
McEwen, B. S. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.008 · Cited by 687
Exploring the association between cannabis use and depression.
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00437.x · Cited by 587 · cited 1×
“There is a reliable association between long-term cannabis use and the development of suicidal ideations and depressive illness (Bovasso 2001; Degenhardt et al. 2003; Lynskey et al. 2004), suggesting that overactive CB1 receptor signaling promotes the development of depression.”
Background
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
Ravinet‐Trillou, C., Delgorge, C., Menet, C., Arnone, M., & Soubrié, P. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802583 · Cited by 583
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
Wong, M., Kling, M. A., Munson, P. J., Listwak, S. J., Licinio, J., Prolo, P., Karp, B., McCutcheon, I. E., Geracioti, T. D., DeBellis, M. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.325 · Cited by 581
Preclinical models: status of basic research in depression
Nestler, E. J., Gould, E., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01405-1 · Cited by 571
The cannabinoid receptors
Howlett, A. C. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00060-6 · Cited by 562
The cannabinoid system and immune modulation
Klein, T., Newton, C. A., Larsen, K. A., Lu, L. D., Perkins, I., Nong, L., & Friedman, H. P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 533
Endocannabinoid Signaling Negatively Modulates Stress-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis
Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475
Self-citation
Regulatory Changes in Neuroendocrine Stress-Integrative Circuitry Produced by a Variable Stress Paradigm
Herman, J. P., Adams, D., & Prewitt, C. M. (2008) · Neuroendocrinology · doi:10.1159/000126839 · Cited by 462
Cannabis Abuse as a Risk Factor for Depressive Symptoms
BOVASSO, G. B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2033 · Cited by 455
Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances ‘Liking’ of a Sweet Reward
Mahler, S. V., Smith, K. S., & Berridge, K. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301376 · Cited by 377
Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress
Hill, M. N., Patel, S., Carrier, E. J., Rademacher, D. J., Ormerod, B. K., Hillard, C. J., & Gorzalka, B. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300601 · Cited by 363
Self-citation
Dexamethasone Suppression Tests in Antidepressant Treatment of Melancholia
Greden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 354
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress
Bortolato, M., Mangieri, R. A., Fu, J., Kim, J. H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.001 · Cited by 347
Comparative analysis of fatty acid amide hydrolase and cb1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling
Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347
Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex
Bambico, F. R., Katz, N., Debonnel, G., & Gobbi, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-07.2007 · Cited by 325
The DST as a predictor of outcome in depression: a meta-analysis
Ribeiro, S. C. M., Tandon, R., Grunhaus, L. J., & Greden, J. F. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1618 · Cited by 321
Cytokine imbalance in the pathophysiology of major depressive disorder
Kim, Y., Na, K.-S., Shin, K.-H., Jung, H., Choi, S., & Kim, J.-B. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.004 · Cited by 319
Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function
Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernández‐Ruíz, J., & Marzo, V. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 313
Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling
Patel, S., Roelke, C. T., Rademacher, D. J., & Hillard, C. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03916.x · Cited by 297
Self-citation
Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
Hill, M., Miller, G., Ho, W.-S., Gorzalka, B., & Hillard, C. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-993211 · Cited by 292
Self-citation
Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats
Xu, Y., Ku, B., Cui, L., Li, X.-J., Barish, P. A., Foster, T. C., & Ogle, W. O. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.071 · Cited by 292
Chronic Mild Stress and Sucrose Consumption: Validity as a Model of Depression
Forbes, N., Stewart, C. A., Matthews, K., & REID, I. (1996) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00305-8 · Cited by 288
Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration
Caillé, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D. G., & Parsons, L. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-06.2007 · Cited by 280
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
Tzavara, E. T., Davis, R. J., Perry, K. W., Li, X., Salhoff, C. R., Bymaster, F. P., Witkin, J. M., & Nomikos, G. G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705100 · Cited by 270
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
Hillard, C. J. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00051-4 · Cited by 261
Self-citation
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents
Griebel, G., Stemmelin, J., & Scatton, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.032 · Cited by 253
Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain
Hillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00087-s · Cited by 233
Self-citation
Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test
Hill, M. N., & Gorzalka, B. B. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.03.003 · Cited by 233
Self-citation
Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims
Hungund, B. L., Vinod, K. Y., Kassir, S. A., Basavarajappa, B. S., Yalamanchili, R., Cooper, T. B., Mann, J. J., & Arango, V. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001376 · Cited by 231
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., & Manzanares, J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.003 · Cited by 218
Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
Gorzalka, B. B., Hill, M. N., & Hillard, C. J. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.004 · Cited by 211
Self-citation
Requirement of Cannabinoid Receptor Type 1 for the Basal Modulation of Hypothalamic-Pituitary-Adrenal Axis Function
Cota, D., Steiner, M.-A., Marsicano, G., Cervino, C., Herman, J. P., Grübler, Y., Stalla, J., Pasquali, R., Lutz, B., Stalla, G. K., et al. (2007) · Endocrinology · doi:10.1210/en.2005-1649 · Cited by 205 · cited 3×
“2002); enhanced activation and impaired inhibition of the hypothalamic-pituitary-adrenal (HPA) axis (Cota et al. 2007); diminished feeding behavior (Ravinet Trillou et al.”
Background
Major Depressive Disorder, Suicidal Ideation, and Suicide Attempt inTwins Discordant for Cannabis Dependence and Early-Onset Cannabis Use
Lynskey, M. T., Glowinski, A. L., Todorov, A. A., Bucholz, K. K., Madden, P. A. F., Nelson, E. C., Statham, D. J., Martin, N. G., & Heath, A. C. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1026 · Cited by 205
Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
Hill, M. N., & Gorzalka, B. B. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00006 · Cited by 196
Self-citation
Lipid signaling: Sleep, synaptic plasticity, and neuroprotection
Chen, C., & Bazan, N. G. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.07.001 · Cited by 193
Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs
Laviolette, S. R., & Grace, A. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0707-06.2006 · Cited by 189
Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
Shearman, L. P., Rosko, K., Fleischer, R., Wang, J., Xu, S., Tong, X., & Rocha, B. A. G. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200312000-00001 · Cited by 188
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression
Koethe, D., Llenos, I. C., Dulay, J. R., Hoyer, C., Torrey, Ε. F., Leweke, F. M., & Weis, S. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0660-5 · Cited by 187
Prefrontal-subcortical and limbic circuit mediation of major depressive disorder
Brody, A. L., Barsom, M. W., Bota, R. G., & Saxena, S. (2001) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2001.21837 · Cited by 181
Endocannabinoids and Vascular Function
Hillard, C. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39035-4 · Cited by 181
Self-citation
Neuromodulatory functions of the endocannabinoid system.
Marsicano, G., & Lutz, B. (2006) · PubMed · Cited by 167
Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference
Hansson, A. C., Bermúdez‐Silva, F. J., Malinen, H., Hyytiä, P., Sánchez-Vera, I., Rimondini, R., de Fonseca, F. R., Kunos, G., Sommer, W. H., & Heilig, M. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301034 · Cited by 167
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropinreleasing hormone
Wrong, M. (2000) · Medical Entomology and Zoology · Cited by 159
Reduced sensitivity to reward in CB1 knockout mice
Sanchis‐Segura, C., Cline, B. H., Marsicano, G., Lutz, B., & Spanagel, R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1877-8 · Cited by 158
Endocannabinoids as cardiovascular modulators
Kunos, G., Járai, Z., Bátkai, S., Goparaju, S. K., Ishac, E. J. N., Liu, J., Wang, L., & Wagner, J. A. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00194-8 · Cited by 158
Differential Regulation of the Endocannabinoids Anandamide and 2-Arachidonylglycerol within the Limbic Forebrain by Dopamine Receptor Activity
Patel, S., Rademacher, D. J., & Hillard, C. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054270 · Cited by 153
Self-citation
Estrogen recruits the endocannabinoid system to modulate emotionality
Hill, M. N., Karacabeyli, E., & Gorzalka, B. B. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.003 · Cited by 153
Self-citation
Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice
Steiner, M. A., Marsicano, G., Nestler, E. J., Holsboer, F., Lutz, B., & Wotjak, C. T. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.008 · Cited by 146
Animal models of depression: are there any?
O'Neil, M. F., & Moore, N. A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.496 · Cited by 140
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain
Valenti, M., Vigan�, D., Casico, M. G., Rubino, T., Steardo, L., Parolaro, D., & Marzo, V. D. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3453-5 · Cited by 135
Role of the endocannabinoid system in depression and suicide
Vinod, K. Y., & Hungund, B. L. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.006 · Cited by 132
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice
Steiner, M. A., Wanisch, K., Monory, K., Marsicano, G., Borroni, E., Bächli, H., Holsboer, F., Lutz, B., & Wotjak, C. T. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500466 · Cited by 130
Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims
Vinod, K. Y., Arango, V., Xie, S., Kassir, S. A., Mann, J. J., Cooper, T. B., & Hungund, B. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.033 · Cited by 127
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity
Patel, S., Carrier, E. J., Ho, W. ‐. V., Rademacher, D. J., Cunningham, S., Reddy, D. S., Falck, J. R., Cravatt, B. F., & Hillard, C. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400377-jlr200 · Cited by 124
Self-citation
Enhancement of anxiety-like responsiveness to the cannabinoid CB1 receptor agonist HU-210 following chronic stress
Hill, M. N., & Gorzalka, B. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.069 · Cited by 119
Self-citation
Involvement of the Endocannabinoid System in the Ability of Long-Term Tricyclic Antidepressant Treatment to Suppress Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis
Hill, M. N., Ho, W. ‐. V., Sinopoli, K. J., Viau, V., Hillard, C. J., & Gorzalka, B. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301092 · Cited by 118
Self-citation
Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity.
Duncan, G. E., Knapp, D. J., Johnson, K. B., & Breese, G. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12895-4 · Cited by 117
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
Witkin, J. M., Tzavara, E. T., Davis, R. J., Li, X., & Nomikos, G. G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.006 · Cited by 110
The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons
Romero, J., Garcia, L., Cebeira, M., Zadrozny, D., Fernández‐Ruíz, J., & Ramos, J. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00186-a · Cited by 108
Sexual Dysfunction in Major Depression
Williams, K., & Reynolds, M. F. (2006) · CNS Spectrums · doi:10.1017/s1092852900026729 · Cited by 107
Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase
Omeir, R. L., Chin, S. A., Hong, Y. H., Ahern, D. G., & Deutsch, D. G. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00181-5 · Cited by 99
Prolonged glucocorticoid treatment decreases cannabinoid CB 1 receptor density in the hippocampus
Hill, M. N., Carrier, E. J., Ho, W. ‐. V., Shi, L., Patel, S., Gorzalka, B. B., & Hillard, C. J. (2007) · Hippocampus · doi:10.1002/hipo.20386 · Cited by 96
Self-citation
Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward
Rademacher, D. J., & Hillard, C. J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.013 · Cited by 86
Self-citation
Endocannabinoid Metabolic Pathways and Enzymes
Ligresti, A., Cascio, M. G., & Marzo, V. D. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774933104 · Cited by 81
Characterization of Ligand Binding to the Cannabinoid Receptor of Rat Brain Membranes Using a Novel Method: Application to Anandamide
Hillard, C. J., Edgemond, W. S., & Campbell, W. B. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020677.x · Cited by 80
Self-citation
CB1 knockout mice display impaired functionality of 5‐HT1A and 5‐HT2A/C receptors
Mato, S., Aso, E., Castro, E., Martín, M., Valverde, O., Maldonado, R. J., & Pazos, Á. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04961.x · Cited by 80
Antidepressive Treatment with Amitriptyline and Paroxetine: Effects on Saliva Cortisol Concentrations
Deuschle, M., Hamann, B., Meichel, C., Krumm, B., Lederbogen, F., Kniest, A., Colla, M., & Heuser, I. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00014 · Cited by 77
Brain monoamine receptors in a chronic unpredictable stress model in rats
Ossowska, G., Nowak, G., Kata, R., Klenk-Majewska, B., Danilczuk, Z., & Żebrowska-Łupina, I. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170077 · Cited by 76
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
Mangieri, R. A., & Piomelli, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.003 · Cited by 73
Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.
Iredale, P. A., Terwilliger, R. Z., Widnell, K. L., Nestler, E. J., & Duman, R. S. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09538-0 · Cited by 67
Chronic mild stress and depressive disorder: a useful new model?
Reid, I., Forbes, N., Stewart, C. A., & Matthews, K. (1997) · Psychopharmacology · doi:10.1007/s002130050471 · Cited by 58
Effects of antidepressants on monoamine transporters
Langer, S. Z., & Schoemaker, H. E. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90037-1 · Cited by 58
Melatonin protects against the effects of chronic stress on sexual behaviour in male rats
Brotto, L. A., Gorzalka, B. B., & LaMarre, A. K. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00018 · Cited by 56
Self-citation
Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain
Oliva, J. M., Urigüen, L., Pérez-Rial, S., & Manzanares, J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.014 · Cited by 50
Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity
Hill, M. N., Barr, A. M., Ho, W. ‐. V., Carrier, E. J., Gorzalka, B. B., & Hillard, C. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04688.x · Cited by 49
Self-citation
Regulation of axonal development by plasma membrane gangliosides
Abad‐Rodríguez, J., & Robotti, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04713.x · Cited by 29
Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in rats.
Ossowska, G., Nowak, G., Klenk-Majewska, B., Danilczuk, Z., & Zebrowska-Łupina, I. (2002) · PubMed · Cited by 21
P.3.033 Acute and chronic stress alter cannabinoid CB1 receptor function and POMC gene expression in the rat brain
Pérez-Rial, S., Urigüen, L., Palomo, T., & Manzanares, J. (2004) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(04)80413-9 · Cited by 2
P.2.d.016 Effects of combined administration of a selective inhibitor of the FAAH (URB597) and imipramine or citalopram in the forced swimming test in rats
Filip, M., Frankowska, M., Wydra, K., Nowak, E., & McCreary, A. C. (2006) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(06)70387-x · Cited by 1
Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders
(2000) · doi:10.1002/1520-6394(2000)12:1+

Research works printed but not linked: 4

Hillard C. J., 2006, Regulation of cannabinoid receptor expression by chronic unpredictable stress in rats and mice, Soc. Neurosci. Abstr.
Pazos A., 2006, Constitutive activity of cannabinoid CB1 receptors in major depression, Soc. Neurosci. Abstr.
Reich C. G., 2007, Stress‐induced modulation of the endocannabinoid system in the HPA axis: effects of gonadal status, Soc. Neurosci. Abstr.
10.1002/1520-6394(2000)12:1 <2::AID-DA2>3.0.CO;2-4 · DOI

Sorted by citations

The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Neurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 698
Self-citation
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Hillard, C. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.130 · Cited by 449
Self-citation
Neurobiology of chronic mild stress: parallels to major depression
Hill, M. N., Hellemans, K. G. C., Verma, P., Gorzalka, B. B., & Weinberg, J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.001 · Cited by 420
Self-citation
Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366

See all 246

Authors: Hill, M. N., Carrier, E. J., McLaughlin, R. J., Morrish, A. C., Meier, S. E., Hillard, C. J., & Gorzalka, B. B.
Affiliations: University of British Columbia (CA)
Medical College of Wisconsin (US)
Corresponding author: Gorzalka, Boris B.
ORCID: Hill, Matthew N.
Carrier, Erica J.
McLaughlin, Ryan J.
Hillard, Cecilia J.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2008-09
Volume: 106
Issue: 6
Pages: 2322-2336
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1111/j.1471-4159.2008.05567.x
PMC: PMC2606621
OpenAlex: W2009594014
Cited by: 246
References: 98
Citations by year: 2026: 7 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 15 · 2021: 22 · 2020: 16 · 2019: 13 · 2018: 15 · 2017: 13 · 2016: 8 · 2015: 12 · 2014: 17 · 2013: 15 · 2012: 12
FWCI: 11.21
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Michael Smith Health Research BC
National Institutes of Health
Canadian Institutes of Health Research
Natural Sciences and Engineering Research Council of Canada
National Institute on Drug Abuse (DA 16967, R01DA016967)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: endocannabinoid system, depression, chronic unpredictable mild stress, imipramine, antidepressant treatment, fatty acid amide hydrolase, anandamide, regional brain differences, prefrontal cortex, hippocampus, hypothalamus, amygdala, ventral striatum, sexual motivation
MeSH terms: Analgesics, Animals, Antidepressive Agents, Antidepressive Agents, Tricyclic, Arachidonic Acids, Brain, Cyclohexanols, Major Depressive Disorder, Disease Models, Animal, Imipramine, Male, Motivation, Sexual Behavior, Animal, Stress, Psychological, Rats, Long-Evans, Receptor, Cannabinoid, CB1, Rats, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks